Please login to the form below

Not currently logged in
Email:
Password:

Alliance Pharma's profit up 17 per cent

Alliance Pharma has recorded a net profit increase of 17 per cent for the first half of 2011, with sales up 4 per cent

Alliance Pharma has recorded a net profit increase of 17 per cent for the first half of 2011.

The speciality pharmaceutical company made a pre-tax profit of £7m for the period compared to £6m for the first half of 2010.

Sales were also up, increasing by 4 per cent from £23.4m for the first half of 2010 to £24.4m for the same period of 2011.

The company also announced the acquisition of UK marketing rights to six products from Beacon Pharmaceuticals for £2.4m. The products include acne treatment Rizuderm (isotretinoin).

The move follows previous acquisitions for Alliance this year, including the pain relief therapy Anbesol (benzocaine).

Michael Gatenby, chairman of Alliance Pharma, said: "We are delighted with the two earnings-enhancing acquisitions announced so far this year and continue to assess further opportunities."

7th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics